NF-κB as an integrator of diverse signaling pathways: The heart of myocardial signaling?

By Jones W.   Brown Maria   Ren Xiaoping   He Suiwen   McGuinness Michael  

Cardiovascular Toxicology, Vol. 3, Iss. 3, 2003-09 ,pp. : 229-253

Humana Press, Inc

Access to resources Recommend Favorite

Effects of a proteasome inhibitor on the NF-κB signalling pathway in experimental osteoarthritis

By Quan R   Huang Z   Yue Z   Xin D   Yang D   Pan J   Zhang L  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 5, 2013-10 ,pp. : 400-407

Informa Healthcare

Access to resources Recommend Favorite

The NF-κB regulatory network

By Brasier Allan  

Cardiovascular Toxicology, Vol. 6, Iss. 2, 2006-06 ,pp. : 111-130

Humana Press, Inc

Access to resources Recommend Favorite

No effects of adalimumab therapy on the activation of NF-κB in lymphocytes from patients with severe rheumatoid arthritis

By Semmler Marco   Seeck Ulrike   Neustadt Beate   Schulz Martin   Dotzlaw Helmut   Neeck Gunther   Eggert Martin  

Clinical Rheumatology, Vol. 26, Iss. 9, 2007-09 ,pp. : 1499-1504

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin (IL)-6 and receptor activator of nuclear factor (NF)-κB ligand (RANKL) are increased in the serum of a patient with primary pachydermoperiostosis

By Rendina D.   De Filippo G.   Viceconti R.   Soscia E.   Sirignano C.   Salvatore M.   Della Monica M.   Scarano G.   Mossetti G.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 225-229

Informa Healthcare

Access to resources Recommend Favorite